Global X Genomics & Biotechnology ETF (GNOM) Holdings $8.35 -0.16 (-1.88%) Closing price 03/28/2025 03:49 PM EasternExtended Trading$8.58 +0.23 (+2.75%) As of 03/28/2025 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Top 41 GNOM HoldingsRankCompanyCurrent PriceWeightShares Held1NTRANatera$143.94-2.9%6.27%23,5282BMRNBioMarin Pharmaceutical$71.44-1.9%5.08%39,8403VCYTVeracyte$30.12-3.2%4.88%85,9604QGENQiagen$39.86+0.5%4.52%64,4125AAgilent Technologies$116.55-2.0%4.50%20,9886CRSPCRISPR Therapeutics$36.99-2.8%4.45%60,6257TECHBio-Techne$58.73-2.0%4.33%40,2378BNTXBioNTech$94.95-0.5%4.31%25,1279LEGNLegend Biotech$35.06-0.9%4.27%63,46710ALNYAlnylam Pharmaceuticals$268.46-0.9%4.26%9,440 Get the Latest News and Ratings for GNOM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. 11Genscript Biotech CorporationN/A4.17%1,384,21812BEAMBeam Therapeutics$22.21+0.1%3.86%94,65213ARWRArrowhead Pharmaceuticals$13.82+0.1%3.77%140,05114RAREUltragenyx Pharmaceutical$37.82-2.8%3.53%50,99115RNAAvidity Biosciences$31.60-2.9%3.37%61,43016MRNAModerna$31.12-3.1%3.02%52,23017GILDGilead Sciences$111.79+0.6%3.01%15,97018ILMNIllumina$80.00-2.8%2.95%19,52219SRPTSarepta Therapeutics$70.41-1.9%2.81%21,48620VRTXVertex Pharmaceuticals$492.69-2.0%2.71%2,98521TXG10x Genomics$9.16-2.7%2.33%131,57022CDNACareDx$17.96-2.1%2.19%65,15123NTLAIntellia Therapeutics$8.07-3.9%2.04%131,75124MYGNMyriad Genetics$8.88-3.7%2.04%115,39525RCKTRocket Pharmaceuticals$7.59-3.7%1.64%110,67826QUREuniQure$12.47-5.0%1.47%59,42227VIRVir Biotechnology$6.70+0.4%1.42%116,37228RGNXREGENXBIO$7.83-1.0%0.87%58,68729VERVVerve Therapeutics$5.22-1.1%0.81%82,43130FLGTFulgent Genetics$17.05+1.2%0.78%26,04231PACBPacific Biosciences of California$1.14-8.1%0.77%342,23632MRVIMaravai LifeSciences$2.36+0.4%0.66%155,11333SANASana Biotechnology$1.71-7.3%0.66%163,72734TSVT2seventy bio$4.950.58%65,24935ALLOAllogene Therapeutics$1.55-0.6%0.54%186,16536SGMOSangamo Therapeutics$0.82-4.4%0.38%256,25437EDITEditas Medicine$1.25-3.8%0.26%104,90338CRBUCaribou Biosciences$0.94-5.0%0.19%105,87239LYELLyell Immunopharma$0.54-8.8%0.17%176,30240CashN/A0.10%56,732Trump to unlock 15-figure fortune for America (May 3rd) ? (Ad)We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public. But something even more spectacular is bound to happen. And those who know what to expect could make41SCLXScilex$0.24-2.0%0.00%226,071 Geographic ExposureUnited States85.6%Netherlands4.6%Switzerland4.2%Cayman Islands4.0%Currency ExposureUSD76.1%HKD4.0%Sector ExposureHealth Care66.7%Energy1.1%Industry ExposureBiotechnology34.0%Health Care Equipment & Supplies21.6%Health Care Providers & Services7.1%Life Sciences Tools & Services4.0%Renewable Energy1.1%SubIndustry ExposureBiotechnology33.5%Life Sciences Tools & Services23.4%Health Care Services7.1%Health Care Equipment2.2%Renewable Energy Equipment1.1% Related Companies and Tools Related Companies HECO Holdings ZAP Holdings TARK Holdings UFO Holdings VOLT Holdings SARK Holdings AGNG Holdings HRTS Holdings FMED Holdings VPN Holdings This page (NASDAQ:GNOM) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.